Views & Analysis Frontiers Health 2017 Live Blog - Day One coverage The pharmaphorum team were on site and reporting live with all the key learnings and insights from Frontiers Health 2017.
Views & Analysis Tunnah’s musings: Healthcare convergence at the frontiers of... Paul Tunnah considers how traditional medicine, data and technology are coming together to address health needs.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
R&D Sponsored The future of cardiometabolic trials: From obesity to outcom... Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO
